Three‐Week Thyroxine Withdrawal: A Thyroid‐Specific Quality of Life Study
- 1 February 2006
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 116 (2) , 250-253
Abstract
The purpose of this study is to determine the impact of a 3-week T4 withdrawal test on the quality of life (QOL) of patients undergoing investigation for residual/recurrent well-differentiated thyroid cancer. Prospective survey study. 181 patients with well-differentiated thyroid cancer were surveyed using a thyroid-specific QOL-thyroid survey at three times throughout the study: prior to T4 withdrawal, after the 3-week withdrawal period, and 4 weeks after resuming T3/T4 combination therapy. A very small, though statistically significant, reduction was observed in the four domains of QOL defined by the QOL-thyroid survey from baseline values to 3 weeks after T4 withdrawal. The maximal difference was 2.04 (fatigue), out of a possible 10 point score, in the physical well-being category. The thyroid-specific QOL questionnaire demonstrates a statistically significant though very small and probably not clinically significant reduction in the QOL of thyroid cancer patients undergoing an induced 3-week hypothyroid state. Three-week T4 withdrawal is a simple, cost-effective, and readily available test.Keywords
This publication has 10 references indexed in Scilit:
- Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinomaJournal of Endocrinological Investigation, 2003
- Recombinant Human Thyrotropin and Thyroid Cancer ManagementThe Journal of Clinical Endocrinology & Metabolism, 2003
- A Consensus Report of the Role of Serum Thyroglobulin as a Monitoring Method for Low-Risk Patients with Papillary Thyroid CarcinomaThe Journal of Clinical Endocrinology & Metabolism, 2003
- A Comparison of Recombinant Human Thyrotropin and Thyroid Hormone Withdrawal for the Detection of Thyroid Remnant or CancerThe Journal of Clinical Endocrinology & Metabolism, 1999
- Papillary and Follicular Thyroid CarcinomaNew England Journal of Medicine, 1998
- Quality-of-Life Changes in Patients with Thyroid Cancer After Withdrawal of Thyroid Hormone TherapyThyroid®, 1997
- Spectrum of quality of life impairment in hypothyroidismQuality of Life Research, 1994
- Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study)The Journal of Clinical Endocrinology & Metabolism, 1994
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- STATISTICAL METHODS APPLIED TO THE DIAGNOSIS OF HYPOTHYROLDISMQJM: An International Journal of Medicine, 1969